Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
A-Alpha Bio logo

A-Alpha Bio

Recent Finacing

Equity

Recent Raise

$14.5M

A-Alpha Bio operates AlphaSeq, a yeast-based platform measuring millions of protein–protein affinities, and AlphaBind, ML models predicting binding from sequence, to support antibody discovery and therapeutic engineering.

Founded 2017
Washington, United States
101-250
Private
aalphabio.com

Highlights

Focus Areas

Biotechnology
Health Care
Life Science
Therapeutics

Recent Investors

Madrona Venture Group logo
Perceptive Xontogeny Venture Fund logo
Department of Defense logo
Breakout Ventures logo
Lux Capital logo
W
AME Cloud Ventures logo
OS Fund logo
Sahsen Ventures logo
Boom Capital logo
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense logo
National Science Foundation logo

Financials

$63.4M

Total Raised

7

Funding rounds

12

Investors


Team

Upgrade to view the team

See the team members at A-Alpha Bio.